The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Astal Laboratories Ltd

Astal Laboratories Ltd

BSE 512600 · NSE ASTALLTD · ISIN INE307N01014 · Group X · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹80.60

-1.38%

BSE close, 28 August 2026

Market cap

₹353.02 cr

4.4 cr shares · Micro cap

Free float

₹222.59 cr

as published

P/E · P/B

36.3× · 11.98×

EPS ₹2.22 · BV ₹6.73

FY25-26 rev / PAT

156.00 / 8.12

₹ cr, as filed

Filings, window

16

3 selected · 19%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹60.45 52-WK HIGH ₹103.20 ₹80.60 47% of range
Against 52-week high-21.9%
Against 52-week low+33.3%
Day change-1.38%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹2.22
Price / earnings36.31×
Price / book11.98×
Book value — derived, price ÷ P/B₹6.73
Return on equity33.03%
Operating margin13.82%
Net margin9.38%

Consistency check

P/B ÷ P/E, which must equal ROE
32.99%
ROE as published
33.03%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 39.51 3.71 0.86 13.82% 9.38%
Mar-26 · Q 40.92 1.09 0.29 5.52% 2.65%
FY25-26 156.00 8.12 4.76 8.31% 5.20%

Quarter on quarter

Revenue, quarter on quarter
-3.4%
Net profit, quarter on quarter
+240.4%
Operating margin, quarter on quarter
+830 bps

Disclosure profile 16 filings in the window

0 median 17.0 p75 · 25 sector max 52 16 47th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Board Outcome2
Results1
Selected sub-total3
Procedural
AGM / EGM4
General3
Annual Report1
Board Meeting1
Newspaper Publication1
Other Update1
PIT / Insider Policy1
Trading Window1
Procedural sub-total13
Total16

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group X, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

16 filings · 3 selected · busiest 2026-09-30

Filing rhythm · the twelve most recent

2026-09-042026-09-30

SelectedProcedural

Filings

16 in the window · 5 earlier on record

  1. 30 September 2026 ·

    AGM / EGM

    Shareholders Meeting- Voting Results Of 33Rd AGM

    Submission of Voting Results.

    AGM/EGM / AGM View filing →

  2. 30 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Submission of voting Results with scrutinizers report.

    AGM/EGM / AGM View filing →

  3. 30 September 2026 ·

    Trading Window

    Closure of Trading Window

    Submission of Trading window closure Intimation.

    Insider Trading / SAST / Closure of Trading Window View filing →

  4. 30 September 2026 ·

    General

    Appointment Of Cost Auditor, Secretarial Auditor And Internal Auditor On Material Subsidiary Of The Company.

    Attached.

    Company Update / General View filing →

  5. 30 September 2026 ·

    General

    Appointment Of Company Secretary In Material Wholly Owned Subsidary.

    Attached

    Company Update / General View filing →

  6. 29 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Submission of outcome of 33rd Annual General Meeting.

    AGM/EGM / AGM View filing →

  7. 11 September 2026 ·

    PIT / Insider Policy

    Code of Conduct under SEBI (PIT) Regulations, 2015

    Submission of Intimation under SEBI (PIT) Regulations, 2015.

    Company Update / Code of Conduct under SEBI (PIT) Regulations, 2015 View filing →

  8. 9 September 2026 ·

    Newspaper Publication

    Newspaper Publication

    Submission of newspaper publication of AGM Notice.

    Company Update / Newspaper Publication View filing →

  9. 7 September 2026 ·

    General

    Letter Of Annual Report & AGM Notice Web Link.

    Attached.

    Company Update / General View filing →

  10. 7 September 2026 ·

    AGM / EGM

    Shareholders Meeting - Notice Of 33Rd Annual General Meeting To Be Held On Tuesday 29Th September, 2026 Through VC/OAVM

    Submission of 33rd AGM Notice.

    AGM/EGM / AGM View filing →

  11. 7 September 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    Submission of Annual Report for the financial year ended March 31, 2026.

    Others / Reg. 34 (1) Annual Report View filing →

  12. 4 September 2026 ·

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting Held On Friday, 04Th September, 2026

    Submission of outcome of the meeting of the Board of Directors.

    Board Meeting / Outcome of Board Meeting View filing →

  13. 31 August 2026 ·

    Board Meeting

    Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Friday, 04Th September, 2026

    Astal Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/09/2026 ,inter alia, to consider and approve 1. To Consider & to approve ....

    Board Meeting / Board Meeting View filing →

  14. 14 August 2026 ·

    Other Update

    Compliances- Statement Of Deviation & Variation

    Submission of Statement of Deviation & Variation

    Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation View filing →

  15. 14 August 2026 ·

    Results

    Results- Financial Results For June 30, 2026

    Submission of Financial Results for the quarter ended June 30, 2026.

    Result / Financial Results View filing →

  16. 14 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting Held On Friday, 14Th August, 2026

    Submission of Outcome of Board Meeting.

    Board Meeting / Outcome of Board Meeting View filing →

RSS feed for Astal Laboratories Ltd · the 50 most recent filings